Facts and controversies in the treatment of cardiac insufficiency
Guérot, C.
Archives des Maladies du Coeur et des Vaisseaux 93(Special Issue 2): 5-6
2000
ISSN/ISBN: 0003-9683 PMID: 10830081 Document Number: 523575
Document emailed within 1 workday
Related Documents
Dodig, S.; Cepelak, I. 2004: The facts and controversies about selenium Acta Pharmaceutica 54(4): 261-276Sibony, O.; Touitou, S.; Oury, J.F.; Luton, D.; Blot, P. 2002: Twin delivery: facts and controversies Journal de Gynecologie Obstetrique et Biologie de la Reproduction 31(1 Suppl): 2s28-2s31
Rezaković, S.; Bukvić Mokos, Z.; Basta-Juzbašić, A. 2012: Acne and diet: facts and controversies Acta Dermatovenerologica Croatica: Adc 20(3): 170-174
Leijten, F.S.; de Weerd, A.W. 1996: Critical illness polyneuropathy, facts and controversies Journal of the Peripheral Nervous System: Jpns 1(1): 28-33
Waugh, M. 2010: The role of condom use in sexually transmitted disease prevention: facts and controversies Clinics in Dermatology 28(5): 549-552
Arnanz Velasco, F.; Andreu Sánchez, J.L. 2004: Controversies and facts about the hormonal replacement therapy for prevention of osteoporosis in postmenopausal women Revista Clinica Espanola 204(2): 101-102
Bogliolo, L. 1976: Anatomie causes of cardiac insufficiency in chronic chagasic cardiopathy (myocarditis) studied in comparison to anatomic causes of cardiac insufficiency in other cardiopathies. Part i Arquivos Brasileiros de Cardiologia 29(5): 419-424
Mareev, V.I.; Lopatin, I.M.; Dzhakhangirov, T.S.; Gkhani, P.; Ageev, F.T.; Belenkov, I.N. 1993: Comparative study on use of angiotensin-converting enzyme inhibitors and cardiac glycosides in the treatment of cardiac insufficiency Kardiologiia 33(12): 23-31; 3-4
Masliuk, V.I.; Popov, V.G.; Popova, T.A.; Litvintsev, V.P. 1972: Treatment of cardiac insufficiency with cardiac glycosides in a complex with preparations effecting nucleic acid synthesis and energy formation Kardiologiia 12(1): 45-52
Vasconcelos-Allende, M.; Unda-Ugalde, J.M. 1996: Levonorgestrel contraceptive implants. Facts and controversies of a current contraceptive method Ginecologia y Obstetricia de Mexico 64: 498-502
Vasconcelos-Allende, M.; Unda-Ugalde, J.M. 1996: Levonorgestrel contraceptive implants. Facts and controversies of a current contraceptive method Ginecologia y Obstetricia de Mexico 64: 498-502
Breithaupt, H. 1979: Treatment of cardiac insufficiency. 2 Die Medizinische Welt 30(38): 1383-1387
Tomov, L.; Orbetsov, M.; Tomov, I.; Todorova, M.; Visheva, N. 1979: Treatment of cardiac insufficiency with lanatigen C Vutreshni Bolesti 18(3): 181-190
Biollaz, J.; Munafo, A. 1988: The treatment of cardiac insufficiency with vasodilators Schweizerische Medizinische Wochenschrift 118(17): 616-620
Turini, G.A. 1983: Treatment of chronic cardiac insufficiency in 1983 Schweizerische Medizinische Wochenschrift 113(26): 951-956
Mukharliamov, N.M. 1981: Peripheral vasodilators in the treatment of cardiac insufficiency Terapevticheskii Arkhiv 53(8): 7-10
Ianovskiĭ, G.V.; Zhadan, I.V. 1970: Treatment of early cardiac insufficiency in hypertensive disease Klinicheskaia Meditsina 48(4): 104-108
Hess, O.M.; Krayenbühl, H.P. 1984: Treatment of cardiac insufficiency within the framework of hypertrophic cardiomyopathy Therapeutische Umschau. Revue Therapeutique 41(2): 138-141
Bersi, M.; Bocchiola, M. 1970: Effectiveness of the use of desacetyl-lanatoside C in the treatment of cardiac insufficiency Minerva Cardioangiologica 18(7): 449-456
Furman, S. 1977: Controversies in cardiac pacing Cardiovascular Clinics 8(1): 301-317